Drugs

Shortage list of veterinary medicines and vaccine

2021-06-10
Shortage list of veterinary medicines and vaccine
Has the page content helped you?

"SFDA" Withdraws and Suspends the Registration of (Omiz Plus 20mg, 40mg)

The Saudi Food & Drug Authority (SFDA) has announced the withdrawal and suspension of registration of Omiz Plus 40/1100mg Capsule with registration number (244-277-12), and Omiz Plus 20/1100 mg Capsule with registration number (245-277-12).

SFDA added that, the medicines produced by Tabuk Pharmaceuticals.  

  • To report sector-related issues

  • Call Centre 19999

Other Warnings

All Warnings

Regulations and Requirements for the clearance of medicines, pharmaceutical products, medical devices, and food products that arrive for pilgrims use

2024-04-29
Regulations and Requirements for the clearance of medicines, pharmaceutical products, medical devices, and food products that arrive for pilgrims use
Guide
Has the page content helped you?

Investor Guide to Obtain Scientific Office Licensing

2019-04-14
Investor Guide to Obtain Scientific Office Licensing
Guide
Has the page content helped you?

Guide for Investor to Obtain a Pharmaceutical Manufacturer License

2020-01-01
Guide for Investor to Obtain a Pharmaceutical Manufacturer License
Guide
Has the page content helped you?

Extending Validity Period for Pharmaceutical Products

2020-04-06
Extending Validity Period for Pharmaceutical Products
Guide
Has the page content helped you?
Warning Date
    2021-03-25

“SFDA” Suspends and Withdraws the Registration of (LORA S Tablet‎) and (LORINASE Tablet‎)

2021-03-25

The Saudi Food & Drug Authority (SFDA) has announced the withdrawal and suspension of registration of the pharmaceutical product (LORA S Tablet, batch number (8-968-15)) and (LORINASE TABLETS, batch number (250-212-09) ‎).

SFDA added that (LORA S Tablet‎) is marketed by Dammam Pharma Company, whether the other product (LORINASE Tablet‎)

  • To report sector-related issues

  • Call Centre 19999

Other Warnings

All Warnings
Warning Date
    2021-03-15

“SFDA” Withdraws and Suspends the Registration of Pharmaceutical Product “Proton”

2021-03-15

The Saudi Food & Drug Authority (SFDA) has announced the withdrawal and suspension of registration of the pharmaceutical product “PROTON 40mg E.C TABLET, batch number (134-212-01 &134-212-01) and “PROTON 20mg E.C TABLET, batch number (134-212-01 &135-212-01),

The Proton brand was manufactured by the Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO)

  • To report sector-related issues

  • Call Centre 19999

Other Warnings

All Warnings

Clearance Conditions and Requirements

2021-02-08
Clearance Conditions and Requirements
Requirement
Has the page content helped you?

SFDA, OIC Conclude Joint Workshops

2021-03-24

Saudi Food and Drug Authority (SFDA) and the Secretariat General of the Organization of Islamic Cooperation (OIC) concluded today workshops that targeted OIC member states in the fields of organizing medical devices and products , and pharmacovigilance.
The third and final workshop, which was held on March 22-23, addressed the pharmacovigilance subject, during which discussions went over medicinal risks, monitoring the safety of proactive medicines and medicinal errors.

Other News

News List
Subscribe to Drugs